Durability of neutralizing antibodies against yellow fever virus after vaccination in healthy adults. 2023

Riccardo De Santis, and Giovanni Faggioni, and Alessandra Amoroso, and Andrea Ciammaruconi, and Alice Pomponi, and Maria Stella Lia, and Donatella Amatore, and Filippo Molinari, and Giancarlo Petralito, and Paola Stefanelli, and Giovanni Rezza, and Florigio Lista
Scientific Department, Army Medical Center, Rome, Italy.

In accordance with the World Health Organization, one dose of yellow fever vaccine may guarantee protection lifelong in healthy adults. However, relatively little information is still available from ad hoc studies. We evaluated the persistence of neutralizing antibodies, which are considered to be an immune correlate of protection, in a large number of military personnel vaccinated up to 47 years before. Overall, 322 individuals were studied. The median time from vaccination to blood collection for neutralizing antibody evaluation was 9 years, ranging from <1 to 47 years. Of the 322 participants, 319 had neutralizing antibodies (99.1 %). The highest median PRNT50 value was observed in those vaccinated ≤1 year before (median PRNT50 = 320). In conclusion, our study confirms on a larger scale that, in healthy adults, neutralizing antibodies may persist as long as 47 years after a single yellow fever vaccines dose.

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D014611 Vaccination Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis. Immunization, Active,Active Immunization,Active Immunizations,Immunizations, Active,Vaccinations
D015004 Yellow Fever An acute infectious disease primarily of the tropics, caused by a virus and transmitted to man by mosquitoes of the genera Aedes and Haemagogus. The severe form is characterized by fever, HEMOLYTIC JAUNDICE, and renal damage. Fever, Yellow,Fevers, Yellow,Yellow Fevers
D015005 Yellow fever virus The type species of the FLAVIVIRUS genus. Principal vector transmission to humans is by AEDES spp. mosquitoes.
D057134 Antibodies, Neutralizing Antibodies that reduce or abolish some biological activity of a soluble antigen or infectious agent, usually a virus. Neutralizing Antibodies,Antibody, Neutralizing,Neutralizing Antibody
D022341 Yellow Fever Vaccine Vaccine used to prevent YELLOW FEVER. It consists of a live attenuated 17D strain of the YELLOW FEVER VIRUS. Fever Vaccine, Yellow,Vaccine, Yellow Fever

Related Publications

Riccardo De Santis, and Giovanni Faggioni, and Alessandra Amoroso, and Andrea Ciammaruconi, and Alice Pomponi, and Maria Stella Lia, and Donatella Amatore, and Filippo Molinari, and Giancarlo Petralito, and Paola Stefanelli, and Giovanni Rezza, and Florigio Lista
January 2018, Journal of travel medicine,
Riccardo De Santis, and Giovanni Faggioni, and Alessandra Amoroso, and Andrea Ciammaruconi, and Alice Pomponi, and Maria Stella Lia, and Donatella Amatore, and Filippo Molinari, and Giancarlo Petralito, and Paola Stefanelli, and Giovanni Rezza, and Florigio Lista
April 2017, Revista do Instituto de Medicina Tropical de Sao Paulo,
Riccardo De Santis, and Giovanni Faggioni, and Alessandra Amoroso, and Andrea Ciammaruconi, and Alice Pomponi, and Maria Stella Lia, and Donatella Amatore, and Filippo Molinari, and Giancarlo Petralito, and Paola Stefanelli, and Giovanni Rezza, and Florigio Lista
January 1947, Medecine et hygiene,
Riccardo De Santis, and Giovanni Faggioni, and Alessandra Amoroso, and Andrea Ciammaruconi, and Alice Pomponi, and Maria Stella Lia, and Donatella Amatore, and Filippo Molinari, and Giancarlo Petralito, and Paola Stefanelli, and Giovanni Rezza, and Florigio Lista
January 1973, Archiv fur die gesamte Virusforschung,
Riccardo De Santis, and Giovanni Faggioni, and Alessandra Amoroso, and Andrea Ciammaruconi, and Alice Pomponi, and Maria Stella Lia, and Donatella Amatore, and Filippo Molinari, and Giancarlo Petralito, and Paola Stefanelli, and Giovanni Rezza, and Florigio Lista
January 2017, PloS one,
Riccardo De Santis, and Giovanni Faggioni, and Alessandra Amoroso, and Andrea Ciammaruconi, and Alice Pomponi, and Maria Stella Lia, and Donatella Amatore, and Filippo Molinari, and Giancarlo Petralito, and Paola Stefanelli, and Giovanni Rezza, and Florigio Lista
July 1948, Paris medical,
Riccardo De Santis, and Giovanni Faggioni, and Alessandra Amoroso, and Andrea Ciammaruconi, and Alice Pomponi, and Maria Stella Lia, and Donatella Amatore, and Filippo Molinari, and Giancarlo Petralito, and Paola Stefanelli, and Giovanni Rezza, and Florigio Lista
September 2018, Nederlands tijdschrift voor geneeskunde,
Riccardo De Santis, and Giovanni Faggioni, and Alessandra Amoroso, and Andrea Ciammaruconi, and Alice Pomponi, and Maria Stella Lia, and Donatella Amatore, and Filippo Molinari, and Giancarlo Petralito, and Paola Stefanelli, and Giovanni Rezza, and Florigio Lista
January 1962, Bulletin of the World Health Organization,
Riccardo De Santis, and Giovanni Faggioni, and Alessandra Amoroso, and Andrea Ciammaruconi, and Alice Pomponi, and Maria Stella Lia, and Donatella Amatore, and Filippo Molinari, and Giancarlo Petralito, and Paola Stefanelli, and Giovanni Rezza, and Florigio Lista
March 1968, Nederlands tijdschrift voor geneeskunde,
Riccardo De Santis, and Giovanni Faggioni, and Alessandra Amoroso, and Andrea Ciammaruconi, and Alice Pomponi, and Maria Stella Lia, and Donatella Amatore, and Filippo Molinari, and Giancarlo Petralito, and Paola Stefanelli, and Giovanni Rezza, and Florigio Lista
January 1953, Jornal de pediatria,
Copied contents to your clipboard!